| Literature DB >> 33080259 |
Sumra Nazir1, Vera Jankowski2, Guzide Bender1, Stephen Zewinger3, Kerry-Anne Rye4, Emiel P C van der Vorst5.
Abstract
High-density lipoprotein (HDL) plays an important role in lipid metabolism and especially contributes to the reverse cholesterol transport pathway. Over recent years it has become clear that the effect of HDL on immune-modulation is not only dependent on HDL concentration but also and perhaps even more so on HDL function. This review will provide a concise general introduction to HDL followed by an overview of post-translational modifications of HDL and a detailed overview of the role of HDL in inflammatory diseases. The clinical potential of HDL and its main apolipoprotein constituent, apoA-I, is also addressed in this context. Finally, some conclusions and remarks that are important for future HDL-based research and further development of HDL-focused therapies are discussed.Entities:
Keywords: Auto-immune diseases; Chronic kidney disease; High-density lipoproteins; Infectious diseases; Inflammation; Metabolic diseases; Neurological diseases
Year: 2020 PMID: 33080259 DOI: 10.1016/j.addr.2020.10.006
Source DB: PubMed Journal: Adv Drug Deliv Rev ISSN: 0169-409X Impact factor: 15.470